News
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
10 Apr 24
News
Needham Reiterates Buy on Cytokinetics, Maintains $108 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Truist Securities Reiterates Buy on Cytokinetics, Maintains $86 Price Target
8 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Cytokinetics Says It Presented Additional 48-Week Data From FOREST-HCM, The Open Label Extension Clinical Study of Aficamten, At The American College Of Cardiology 73ʳᵈ Annual Scientific Session
5 Apr 24
News
$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
3 Apr 24
News, Trading Ideas
Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
15 Mar 24
News, Trading Ideas
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $77
7 Mar 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Outperform on Cytokinetics, Maintains $107 Price Target
4 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Unpacking the Latest Options Trading Trends in Cytokinetics
28 Feb 24
Options, Markets
HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $94 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on Cytokinetics, Maintains $108 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Cytokinetics Anticipates 2024 Revenue Of $3M-$5M; Approximately 2 Years Of Cash Runway
27 Feb 24
News, Guidance
Cytokinetics Q4 2023 GAAP EPS $(1.38) Misses $(0.97) Estimate, Sales $1.67M Miss $10.77M Estimate
27 Feb 24
Earnings, Earnings Misses, News
Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
27 Feb 24
News, Trading Ideas
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Cytokinetics Now Presenting At Oppenheimer 34th Annual Healthcare Life Sciences Conference; Shares See Volume
13 Feb 24
News, Events
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
9 Feb 24
News, Trading Ideas
Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
5 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
2 Feb 24
News, Trading Ideas
UBS Downgrades Cytokinetics to Neutral, Raises Price Target to $92
24 Jan 24
News, Downgrades, Price Target, Analyst Ratings
Press releases
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
10 Apr 24
Biotech, News, Press Releases, General
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
5 Apr 24
Biotech, Press Releases, General
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Apr 24
Biotech, Press Releases, General
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
1 Apr 24
Biotech, Health Care, Press Releases, General
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
25 Mar 24
Biotech, News, Health Care, Press Releases, General
Cytokinetics to Participate in March Investor Conferences
4 Mar 24
Biotech, News, Press Releases, General
Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
1 Mar 24
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Mar 24
Biotech, Press Releases, General
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
29 Feb 24
Biotech, Press Releases, General
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
28 Feb 24
Biotech, Press Releases, General
Cytokinetics Reports Fourth Quarter 2023 Financial Results
27 Feb 24
Earnings, Press Releases
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
13 Feb 24
Biotech, News, Press Releases, General
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
6 Feb 24
Biotech, News, Press Releases, General
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
29 Jan 24
Biotech, Press Releases, General
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten
25 Jan 24
Biotech, Press Releases, General